1. Background {#sec0005}
=============

Von Hippel-Lindau disease (vHL disease) is an autosomal dominantly inherited disease in which multiple neoplastic lesions develop in many organs. Of these, 8--17% are associated with pancreatic neuroendocrine tumors (PNETs) \[[@bib0005]\]. We encountered a case of concomitant bilateral adrenal pheochromocytoma, PNET, and cerebellar hemangioblastoma, which necessitated a two-stage resection for the abdominal lesions. This work has been reported in line with SCARE criteria \[[@bib0010]\].

2. Case presentation {#sec0010}
====================

A 50-year-old woman visited our outpatient clinic owing to cranial lesions, bilateral adrenal lesions, and pancreatic lesions detected during a medical checkup. She had no previous medical history. Her family medical history included renal cell carcinoma in her father and bilateral adrenal pheochromocytoma and spinal hemangioblastoma in her brother. Blood and urine tests were performed at the first visit; the 24-h urine sample showed abnormal normetanephrine levels (2.3 mg/day).

Abdominal contrast-enhanced CT showed a 2.5-cm plethoric tumor in the head of the pancreas ([Fig. 1](#fig0005){ref-type="fig"}). Positron emission tomography--computed tomography demonstrated a 7-cm tumor in the upper pole of the left kidney, with 18F-fluorodeoxyglucose (FDG) accumulation localized to the margin, indicating a mural nodule. T1-weighted contrast-enhanced magnetic resonance imaging of the head demonstrated a high signal intensity area measuring 10 mm in the region from the cerebellar vermis to the left cerebellar hemisphere, indicating hemangioblastoma. Therefore, the patient was diagnosed with vHL disease type 2A simultaneously associated with bilateral pheochromocytomas, PNET, and hemangioblastomas. Owing to the presence of a functional pheochromocytoma, the patient's hemodynamics were unstable. After establishing stable blood pressure control using an α1 receptor antagonist in the Department of Endocrinology, laparoscopic left adrenalectomy and subtotal resection of the right adrenal gland was conducted as cortical sparing surgery in the Department of Urology. During the first surgery, single-incision open laparotomy of the umbilical region was performed. After detaching them from the surrounding organs, the bilateral adrenal gland lesions were excised. No increase in blood pressure was observed. After the first surgery, the clinical course was unremarkable, and the patient was discharged in remission on the sixth postoperative day. She was prescribed 10 mg of oral hydrocortisone to supplement the postoperative steroids; the dose was gradually reduced while screening adrenal function for ambulatory care. The administration of hydrocortison was terminated 5 months after surgery. Subsequently, subtotal stomach-preserving pancreatoduodenectomy with reconstruction was performed. Only minor postoperative adhesions were found around the Gerota's fascia with almost no adherence immediately under the wound. Moreover, the surgery was completed without high blood pressure or acute adrenal insufficiency. The patient's clinical course thereafter was unremarkable and she was discharged in remission on the 11th postoperative day. Currently, she is alive without recurrence at 2 years after surgery for the bilateral adrenal pheochromocytoma and 6 months after the PNET surgery. Furthermore, no neurological symptoms such as paralysis or dizziness have been reported. However, the patient continues to undergo close observation in case the cerebellar lesion grows.Fig. 1Imaging findings.The arterial phase enhanced, multi-detector computed tomography image shows wellenhanced tumors in the head of pancreas, along with high 18F-fluorodeoxyglucose accumulation, but no mass in the body and tail.Fig. 1

Pathologic findings showed a solid tumor with a white tone and a diameter of 25 mm in the head of the pancreas. Immunohistochemistry revealed positive results for chromogranin, synaptophysin, and CD56, with a Ki-67 index of 10--15%. Thus, the 2.5 × 1.5-cm pancreatic head tumor was classified as a T3N0M0 fStage II A NET G2 in accordance with the Union for International Cancer Control TNM 7th edition and WHO 2010 criteria ([Fig. 2](#fig0010){ref-type="fig"}).Fig. 2Pathological findings.The image shows a gross cross-section of the head of the pancreas demonstrating a solid and whitish mass. The solid tumor was a well-differentiated pancreatic endocrine neoplasm with clear cytoplasm (hematoxylin-eosin, ×200). Many cells stained positive chromogranin, and the Ki-67 index was 10--15%.Fig. 2

3. Discussion {#sec0015}
=============

vHL disease is an autosomal dominantly inherited disease complicated by multiple lesions. Of the tumors associated with vHL disease, renal cancer and central nervous system lesions are regarded as prognostic factors. PNET is associated with 8--17% of vHL diseases.

This report presents the first case of a secondary resection after laparoscopic cortical sparing surgery for intraperitoneal lesions due to type 2A vHL disease, which was simultaneously complicated by bilateral pheochromocytoma, PNET, and hemangioblastoma. However, the patient demonstrated good progress after surgery possibly owing to the following reasons: (1) upon resection of the bilateral adrenal pheochromocytoma and partial resection of the right adrenal gland, which preserved adrenal cortical function, pancreaticoduodenectomy could be carried out such that hormonal dynamics were almost normal; and (2) the postoperative clinical course was good and postoperative adhesion was reduced to a minor degree owing to the previous laparoscopic surgery.

A literature review yielded two similar reports in Japan that involved one-stage resections. Although it is difficult to simply compare findings, we concluded that patients undergoing a secondary resection would have no complications and that the hospitalization period is shorter. The merit of secondary resection is that the surgery can be carried out with stable hormonal dynamics. The demerits include (1) adverse effects caused by adhesion due to multiple surgeries and (2) delayed treatment for pancreatic lesions.

Some previous reports recommend laparoscopic primary resection for multiple lesions \[[@bib0015]\]. According to these reports, secondary surgical strategies have the disadvantage of coincidence with the region of skin incision for abdominal lesions, making it difficult to conduct a second and subsequent surgeries due to adhesion. However, owing to laparoscopic surgery, postoperative adhesions can be expected to be relatively minor. Moreover, should the pancreatic lesion demonstrate malignant behavior, the period from diagnosis to resection is expected to be prolonged in cases of secondary resection, with the possibility of advancement of the disease. However, PNET associated with vHL disease does not have a high grade of malignancy \[[@bib0020]\]. Moreover, in cases of laparoscopic resection, recovery from primary surgery is expected to be quick. In our case, the interval between primary and secondary surgeries was 5 months, which is within an acceptable range.

Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for PNET allows for a definite diagnosis of PNET and evaluation of malignancy, which can be used to guide secondary resection strategies. However, with PNET categorized as a heterogeneous tumor, the rate of concordance between the results of EUS-FNA and the final pathology is not high (74%) \[[@bib0025]\]. Additionally, owing to the complications of EUS-FNA treatment, the indication for EUS-FNA is believed to require careful consideration; thus, our department does not carry out EUS-FNA routinely. FDG-PET has been regarded as a preoperative evaluation tool for the grade of malignancy of PNET as a replacement for EUS-FNA. According to previous reports, the SUVmax from FDG-PET for non-hereditary PNET correlates with tumor pathology. On the other hand, PNET associated with vHL disease does not suggest a strong association with findings from FDG-PET \[[@bib0030]\], which are believed to be supplementary at this stage. It is necessary to develop treatment strategies taking into consideration the balance between short-term prognosis and long-term prognosis.

4. Conclusion {#sec0020}
=============

Two-stage resection is a safe and effective treatment for bilateral pheochromocytoma and PNET associated with vHL disease.
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